Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Junshik Hong, Ji Hyun Kim, Kyoung Hwa Lee, Hee Kyung Ahn, Sanghui Park, Sun Jin Sym, Jinny Park, Eun Kyung Cho, Dong Bok Shin & Jae Hoon Lee. (2014) Symptom-oriented clinical detection versus routine imaging as a monitoring policy of relapse in patients with diffuse large B-cell lymphoma. Leukemia & Lymphoma 55:10, pages 2312-2318.
Read now
Read now
Chan Y. Cheah & John F. Seymour. (2014) Adding weight to a sinking ship: more reasons not to perform routine surveillance imaging in patients with diffuse large B-cell lymphoma in remission. Leukemia & Lymphoma 55:10, pages 2223-2225.
Read now
Read now
Martin Hutchings & Aaron Polliack. (2012) When and how to perform surveillance imaging in patients with lymphoma, and is it worth it?. Leukemia & Lymphoma 53:6, pages 1015-1016.
Read now
Read now
Martin Hutchings. (2011) Routine follow-up scanning of patients with lymphoma: who, when, how, and why?. Leukemia & Lymphoma 52:4, pages 552-553.
Read now
Read now
Articles from other publishers (38)
Michael D. Shost, Tarun K. Jella, Andrew A. Ronald, Eric Z. Herring, Martha Sajatovic & Gabriel A. Smith. (2022) Clinical Utility of Routine Postoperative Imaging in Spinal Fusion Surgery: A Systematic Review. World Neurosurgery 167, pages 222-228.e1.
Crossref
Crossref
Max L. Goldman, Jimmy J. Mao, Christopher S. Strouse, Wanqi Chen, Manali Rupji, Zhengjia Chen, Matthew J. Maurer, Oscar Calzada, Michael Churnetski, Christopher R. Flowers, James R. Cerhan, Brian K. Link, Carrie A. Thompson & Jonathon B. Cohen. (2021) Surveillance imaging during first remission in follicular lymphoma does not impact overall survival. Cancer 127:18, pages 3390-3402.
Crossref
Crossref
Kenneth Ofori, Govind Bhagat & Alex J. Rai. (2020) Exosomes and extracellular vesicles as liquid biopsy biomarkers in diffuse large B‐cell lymphoma: Current state of the art and unmet clinical needs. British Journal of Clinical Pharmacology 87:2, pages 284-294.
Crossref
Crossref
Lucia Zanoni, Alessandro Broccoli, Alessandro Lambertini, Cinzia Pellegrini, Vittorio Stefoni, Filippo Lodi, Cristina Fonti, Cristina Nanni, Pier Luigi Zinzani & Stefano Fanti. (2019) Role of 18F-FLT PET/CT in suspected recurrent or residual lymphoma: final results of a pilot prospective trial. European Journal of Nuclear Medicine and Molecular Imaging 46:8, pages 1661-1671.
Crossref
Crossref
C. Bodet-Milin, E. Itti & P.Y. Salaün. (2019) Lymphomes. Médecine Nucléaire 43:1, pages 150-160.
Crossref
Crossref
Justin M. Darrah & Alex F. Herrera. (2018) Updates on Circulating Tumor DNA Assessment in Lymphoma. Current Hematologic Malignancy Reports 13:5, pages 348-355.
Crossref
Crossref
Ghulam Rehman Mohyuddin, Ashley Elizabeth Clark, John Roller, Leyla Shune, Tara Lin, Neil Dunavin, Ajoy Dias, Siddhartha Ganguly, Sunil Abhyankar, Joseph McGuirk & Anurag Singh. (2018) Utility of routine surveillance imaging for diffuse large B-cell lymphoma post autologous transplant: A single center experience. Hematology/Oncology and Stem Cell Therapy 11:3, pages 135-141.
Crossref
Crossref
Christopher Melani, Wyndham H. Wilson & Mark Roschewski. (2018) Monitoring clinical outcomes in aggressive B-cell lymphoma: From imaging studies to circulating tumor DNA. Best Practice & Research Clinical Haematology 31:3, pages 285-292.
Crossref
Crossref
A.M. García Vicente, M.P. Talavera Rubio, E. Dominguez Ferreras, C. Calle Primo, M. Amo-Salas, M.J. Tello Galán, G.A. Jimèc)nez Londoño, F. Jimèc)nez Aragón, B. Hernández Ruiz & Á. Soriano Castrejón. (2018) 18 F-FDG PET/contrast enhanced CT in the standard follow-up of patients with lymphoma. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 37:3, pages 151-155.
Crossref
Crossref
A.M. García Vicente, M.P. Talavera Rubio, E. Dominguez Ferreras, C. Calle Primo, M. Amo-Salas, M.J. Tello Galán, G.A. Jiménez Londoño, F. Jiménez Aragón, B. Hernández Ruiz & Á. Soriano Castrejón. (2018) 18 F-FDG PET/TC con contraste intravenoso en el seguimiento estandarizado de pacientes con linfoma. Revista Española de Medicina Nuclear e Imagen Molecular 37:3, pages 151-155.
Crossref
Crossref
Shawn Karls, Hina Shah & Heather Jacene. (2018) PET/CT for Lymphoma Post-therapy Response Assessment in Other Lymphomas, Response Assessment for Autologous Stem Cell Transplant, and Lymphoma Follow-up. Seminars in Nuclear Medicine 48:1, pages 37-49.
Crossref
Crossref
Tycel Phillips & Jessica Mercer. (2017) Surveillance Scans in Lymphoma: Friend or Foe?. Current Treatment Options in Oncology 18:2.
Crossref
Crossref
Gunjan L. Shah & Craig H. Moskowitz. (2016) Role of Positron Emission Tomography in Diffuse Large B-cell Lymphoma. Hematology/Oncology Clinics of North America 30:6, pages 1215-1228.
Crossref
Crossref
Narendranath Epperla, Namrata Shah, Mehdi Hamadani, Kristin Richardson, Jonathan T. Kapke, Asmita Patel, Sravanthi P. Teegavarapu, George Carrum, Parameswaran N. Hari, Sai R. Pingali, Reem Karmali & Timothy S. Fenske. (2016) Impact of Routine Surveillance Imaging on Outcomes of Patients With Diffuse Large B-Cell Lymphoma After Autologous Hematopoietic Cell Transplantation. Clinical Lymphoma Myeloma and Leukemia 16:12, pages 672-678.
Crossref
Crossref
Mary Kwok, S. Peter Wu, Clifton Mo, Thomas Summers & Mark Roschewski. (2016) Circulating Tumor DNA to Monitor Therapy for Aggressive B-Cell Lymphomas. Current Treatment Options in Oncology 17:9.
Crossref
Crossref
Katell Michaux, Christophe Bergeron, Virginie Gandemer, Françoise Mechinaud, Anne Uyttebroeck & Yves Bertrand. (2016) Relapsed or Refractory Lymphoblastic Lymphoma in Children: Results and Analysis of 23 Patients in the EORTC 58951 and the LMT96 Protocols. Pediatric Blood & Cancer 63:7, pages 1214-1221.
Crossref
Crossref
Gita Thanarajasingam, Nabila Bennani-Baiti & Carrie A. Thompson. (2016) PET-CT in Staging, Response Evaluation, and Surveillance of Lymphoma. Current Treatment Options in Oncology 17:5.
Crossref
Crossref
Luc?a Gra?a, Alfonso Calzado, Paula Hern?ndez & Ricardo Rodr?guez. (2016) Role of computed tomography on large B-cell non-Hodgkin?s lymphoma follow-up and the risk of radiation-induced neoplasm: A retrospective cohort study. European Journal of Radiology 85:3, pages 673-679.
Crossref
Crossref
Mehdi Taghipour, Charles Marcus, Pratyusha Nunna & Rathan M. Subramaniam. (2016) Follow-up FDG PET/CT in Patients With Non-Hodgkin Lymphoma. Clinical Nuclear Medicine 41:2, pages e93-e97.
Crossref
Crossref
Tarec Christoffer El-GalalyLasse Hjort JakobsenMartin HutchingsPeter de Nully BrownHerman Nilsson-EhleElisabeth SzékelyKaren Juul MylamViktoria HjalmarHans Erik JohnsenMartin BøgstedMats Jerkeman. (2015) Routine Imaging for Diffuse Large B-Cell Lymphoma in First Complete Remission Does Not Improve Post-Treatment Survival: A Danish–Swedish Population-Based Study. Journal of Clinical Oncology 33:34, pages 3993-3998.
Crossref
Crossref
Martin Hutchings & Sally Barrington. (2015) FDG-PET for the early treatment monitoring, for final response and follow-up evaluation in lymphoma. Clinical and Translational Imaging 3:4, pages 271-281.
Crossref
Crossref
Lauren Veltri, Bipin N. Savani, Mohamed A. Kharfan‐Dabaja, Mehdi Hamadani & Abraham S. Kanate. 2015. Clinical Guide to Transplantation in Lymphoma. Clinical Guide to Transplantation in Lymphoma
145
159
.
Gregory A. Abel. (2015) Does Surveillance Imaging After Treatment for Diffuse Large B-Cell Lymphoma Really Work?. Journal of Clinical Oncology 33:13, pages 1427-1429.
Crossref
Crossref
Tarec Christoffer El-Galaly & Martin Hutchings. 2015. Non-Hodgkin Lymphoma. Non-Hodgkin Lymphoma
125
146
.
Carrie A. ThompsonHerve GhesquieresMatthew J. MaurerJames R. CerhanPierre BironStephen M. AnsellCatherine Chassagne-ClémentDavid J. InwardsThérèse GargiPatrick B. JohnstonEmmanuelle Nicolas-VirelizierWilliam R. MaconMarie PeixIvana N. MicallefCatherine SebbanGrzegorz S. NowakowskiLuis F. PorrataGeorge J. WeinerThomas E. WitzigThomas M. HabermannBrian K. Link. (2014) Utility of Routine Post-Therapy Surveillance Imaging in Diffuse Large B-Cell Lymphoma. Journal of Clinical Oncology 32:31, pages 3506-3512.
Crossref
Crossref
Ignacio Banzo, Isabel Martínez-Rodríguez, Remedios Quirce, Julio Jiménez-Bonilla & José Manuel Carril. (2014) Diagnosis of Mantle-Cell Lymphoma Relapse by 18F-FDG PET/CT After Water Gastric Distention. Clinical Nuclear Medicine 39:10, pages 931-933.
Crossref
Crossref
Karen Juul Mylam, Anne Lerberg Nielsen, Lars Møller Pedersen & Martin Hutchings. (2014) Fluorine-18-fluorodeoxyglucose Positron Emission Tomography in Diffuse Large B-cell Lymphoma. PET Clinics 9:4, pages 443-455.
Crossref
Crossref
TC El-Galaly, Karen Juul Mylam, Martin Bøgsted, Peter Brown, Maria Rossing, Anne Ortved Gang, Anne Haglund, Bente Arboe, Michael Roost Clausen, Paw Jensen, Michael Pedersen, Anne Bukh, Bo Amdi Jensen, Christian Bjørn Poulsen, Francesco d'Amore & Martin Hutchings. (2014) Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma. American Journal of Hematology 89:6, pages 575-580.
Crossref
Crossref
Ryan C. LynchAndrew D. ZelenetzJames O. ArmitageKenneth R. Carson. (2014) Surveillance Imaging for Lymphoma: Pros and Cons. American Society of Clinical Oncology Educational Book:34, pages e388-e395.
Crossref
Crossref
Sally Fiona Barrington & Nabegh George Mikhaeel. (2014) When should FDG-PET be used in the modern management of lymphoma?. British Journal of Haematology 164:3, pages 315-328.
Crossref
Crossref
Quoc Truong, Nilay Shah, Mark Knestrick, Brendan Curley, Yanqing Hu, Michael Craig & Mehdi Hamadani. (2014) Limited Utility of Surveillance Imaging for Detecting Disease Relapse in Patients With Non-Hodgkin Lymphoma in First Complete Remission. Clinical Lymphoma Myeloma and Leukemia 14:1, pages 50-55.
Crossref
Crossref
É. Herin, J. Chalaye, J.-L. Lagrange, K. Belhadj, É. De Kerviler, A. Luciani, A. Rahmouni & E. Itti. 2014. Imagerie Post-Thérapeutique en Oncologie. Imagerie Post-Thérapeutique en Oncologie
265
298
.
Kamal Patel, Nira Hadar, Jounghee Lee, Barry A. Siegel, Bruce E. Hillner & Joseph Lau. (2013) The Lack of Evidence for PET or PET/CT Surveillance of Patients with Treated Lymphoma, Colorectal Cancer, and Head and Neck Cancer: A Systematic Review. Journal of Nuclear Medicine 54:9, pages 1518-1527.
Crossref
Crossref
Stephan D. Voss. (2013) Surveillance Imaging in Pediatric Hodgkin Lymphoma. Current Hematologic Malignancy Reports 8:3, pages 218-225.
Crossref
Crossref
C Y Cheah, M S Hofman, M Dickinson, A Wirth, D Westerman, S J Harrison, K Burbury, M Wolf, H Januszewicz, K Herbert, H M Prince, D A Carney, D S Ritchie, R J Hicks & J F Seymour. (2013) Limited role for surveillance PET–CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy. British Journal of Cancer 109:2, pages 312-317.
Crossref
Crossref
Irit Avivi, Ariel Zilberlicht, Eldad J. Dann, Ronit Leiba, Tal Faibish, Jacob M. Rowe & Rachel Bar‐Shalom. (2013) Strikingly high false positivity of surveillance FDG‐PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era. American Journal of Hematology 88:5, pages 400-405.
Crossref
Crossref
Stephen M. Ansell & James O. Armitage. (2012) Positron Emission Tomographic Scans in Lymphoma: Convention and Controversy. Mayo Clinic Proceedings 87:6, pages 571-580.
Crossref
Crossref
Peter J. Hosein, Vitor H. Pastorini, Fabio M. Paes, Daryl Eber, Jennifer R. Chapman, Aldo N. Serafini, Ash A. Alizadeh & Izidore S. Lossos. (2011) Utility of positron emission tomography scans in mantle cell lymphoma. American Journal of Hematology 86:10, pages 841-845.
Crossref
Crossref